"use strict";(self.webpackChunkbiominer_components=self.webpackChunkbiominer_components||[]).push([[60],{39060:function(t,e,i){i.r(e),e.default=[{category:"node",cluster:"BiologicalProcess",data:{description:"The removal of one or more electrons from a fatty acid, with or without the concomitant removal of a proton or protons, by reaction with an electron-accepting substance, by addition of oxygen or by removal of hydrogen.",id:"GO:0019395",identity:"BiologicalProcess::GO:0019395",label:"BiologicalProcess",name:"fatty acid oxidation",resource:"GO"},degree:null,id:"BiologicalProcess::GO:0019395",label:"GO:0019395",nlabel:"BiologicalProcess",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"B"},keyshape:{fill:"#b15928",fillOpacity:.95,opacity:.95,stroke:"#b15928"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"fatty acid oxidation"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"BiologicalProcess",data:{description:"Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus reflecting the presence, absence, or concentration of nutrients.",id:"GO:0031669",identity:"BiologicalProcess::GO:0031669",label:"BiologicalProcess",name:"cellular response to nutrient levels",resource:"GO"},degree:null,id:"BiologicalProcess::GO:0031669",label:"GO:0031669",nlabel:"BiologicalProcess",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"B"},keyshape:{fill:"#b15928",fillOpacity:.95,opacity:.95,stroke:"#b15928"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"cellular response to nutrient levels"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"BiologicalProcess",data:{description:"The process whose specific outcome is the progression of the circulatory system over time, from its formation to the mature structure. The circulatory system is the organ system that passes nutrients (such as amino acids and electrolytes), gases, hormones, blood cells, etc. to and from cells in the body to help fight diseases and help stabilize body temperature and pH to maintain homeostasis.",id:"GO:0072359",identity:"BiologicalProcess::GO:0072359",label:"BiologicalProcess",name:"circulatory system development",resource:"GO"},degree:null,id:"BiologicalProcess::GO:0072359",label:"GO:0072359",nlabel:"BiologicalProcess",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"B"},keyshape:{fill:"#b15928",fillOpacity:.95,opacity:.95,stroke:"#b15928"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"circulatory system development"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Compound",data:{description:"A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.",id:"DrugBank:DB00328",identity:"Compound::DrugBank:DB00328",label:"Compound",name:"INDOMETHACIN",resource:"DrugBank"},degree:null,id:"Compound::DrugBank:DB00328",label:"DrugBank:DB00328",nlabel:"Compound",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"C"},keyshape:{fill:"#33a02c",fillOpacity:.95,opacity:.95,stroke:"#33a02c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"INDOMETHACIN"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Compound",data:{description:"A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.",id:"DrugBank:DB00586",identity:"Compound::DrugBank:DB00586",label:"Compound",name:"DICLOFENAC",resource:"DrugBank"},degree:null,id:"Compound::DrugBank:DB00586",label:"DrugBank:DB00586",nlabel:"Compound",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"C"},keyshape:{fill:"#33a02c",fillOpacity:.95,opacity:.95,stroke:"#33a02c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"DICLOFENAC"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Compound",data:{description:"An androstanoid having 17beta-hydroxy and 3-oxo groups, together with unsaturation at C-4-C-5..",id:"DrugBank:DB00624",identity:"Compound::DrugBank:DB00624",label:"Compound",name:"TESTOSTERONE",resource:"DrugBank"},degree:null,id:"Compound::DrugBank:DB00624",label:"DrugBank:DB00624",nlabel:"Compound",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"C"},keyshape:{fill:"#33a02c",fillOpacity:.95,opacity:.95,stroke:"#33a02c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"TESTOSTERONE"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Compound",data:{description:"A member of the class of benzimidazoles carrying a 1,3-thiazol-4-yl substituent at position 2. A mainly post-harvest fungicide used to control a wide range of diseases including Aspergillus, Botrytis, Cladosporium and Fusarium.",id:"DrugBank:DB00730",identity:"Compound::DrugBank:DB00730",label:"Compound",name:"THIABENDAZOLE",resource:"DrugBank"},degree:null,id:"Compound::DrugBank:DB00730",label:"DrugBank:DB00730",nlabel:"Compound",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"C"},keyshape:{fill:"#33a02c",fillOpacity:.95,opacity:.95,stroke:"#33a02c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"THIABENDAZOLE"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Compound",data:{id:"DrugBank:DB01250",identity:"Compound::DrugBank:DB01250",label:"Compound",name:"OLSALAZINE",resource:"DrugBank"},degree:null,id:"Compound::DrugBank:DB01250",label:"DrugBank:DB01250",nlabel:"Compound",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"C"},keyshape:{fill:"#33a02c",fillOpacity:.95,opacity:.95,stroke:"#33a02c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"OLSALAZINE"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Compound",data:{id:"DrugBank:DB04422",identity:"Compound::DrugBank:DB04422",label:"Compound",name:"HOMOCYSTEINE",resource:"DrugBank"},degree:null,id:"Compound::DrugBank:DB04422",label:"DrugBank:DB04422",nlabel:"Compound",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"C"},keyshape:{fill:"#33a02c",fillOpacity:.95,opacity:.95,stroke:"#33a02c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"HOMOCYSTEINE"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Compound",data:{id:"DrugBank:DB04971",identity:"Compound::DrugBank:DB04971",label:"Compound",name:"REGLITAZAR",resource:"DrugBank"},degree:null,id:"Compound::DrugBank:DB04971",label:"DrugBank:DB04971",nlabel:"Compound",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"C"},keyshape:{fill:"#33a02c",fillOpacity:.95,opacity:.95,stroke:"#33a02c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"REGLITAZAR"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Compound",data:{id:"DrugBank:DB05854",identity:"Compound::DrugBank:DB05854",label:"Compound",name:"CLX-0921",resource:"DrugBank"},degree:null,id:"Compound::DrugBank:DB05854",label:"DrugBank:DB05854",nlabel:"Compound",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"C"},keyshape:{fill:"#33a02c",fillOpacity:.95,opacity:.95,stroke:"#33a02c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"CLX-0921"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Compound",data:{id:"DrugBank:DB08915",identity:"Compound::DrugBank:DB08915",label:"Compound",name:"ALEGLITAZAR",resource:"DrugBank"},degree:null,id:"Compound::DrugBank:DB08915",label:"DrugBank:DB08915",nlabel:"Compound",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"C"},keyshape:{fill:"#33a02c",fillOpacity:.95,opacity:.95,stroke:"#33a02c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"ALEGLITAZAR"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Compound",data:{description:"An aromatic ether that has formula C24H24N4O5S.",id:"DrugBank:DB09198",identity:"Compound::DrugBank:DB09198",label:"Compound",name:"LOBEGLITAZONE",resource:"DrugBank"},degree:null,id:"Compound::DrugBank:DB09198",label:"DrugBank:DB09198",nlabel:"Compound",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"C"},keyshape:{fill:"#33a02c",fillOpacity:.95,opacity:.95,stroke:"#33a02c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"LOBEGLITAZONE"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Compound",data:{id:"DrugBank:DB11811",identity:"Compound::DrugBank:DB11811",label:"Compound",name:"ARHALOFENATE",resource:"DrugBank"},degree:null,id:"Compound::DrugBank:DB11811",label:"DrugBank:DB11811",nlabel:"Compound",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"C"},keyshape:{fill:"#33a02c",fillOpacity:.95,opacity:.95,stroke:"#33a02c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"ARHALOFENATE"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Compound",data:{id:"MESH:C513115",identity:"Compound::MESH:C513115",label:"Compound",name:"1-(methylimino-N-oxy)-6-(2-morpholinoethoxy)-3-phenyl-1H-indene-2-carboxylic acid ethyl ester",resource:"DrugBank"},degree:null,id:"Compound::MESH:C513115",label:"MESH:C513115",nlabel:"Compound",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"C"},keyshape:{fill:"#33a02c",fillOpacity:.95,opacity:.95,stroke:"#33a02c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"1-(methylimino-N-oxy)-6-(2-morpholinoethoxy)-3-phenyl-1H-indene-2-carboxylic acid ethyl ester"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Compound",data:{id:"MESH:C541580",identity:"Compound::MESH:C541580",label:"Compound",name:"(S)-2-ethoxy-3-(4-(5-(4-(5-(methoxymethyl)isoxazol-3-yl)phenyl)-3-methylthiophen-2-yl)methoxyphenyl)propanoic acid",resource:"DrugBank"},degree:null,id:"Compound::MESH:C541580",label:"MESH:C541580",nlabel:"Compound",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"C"},keyshape:{fill:"#33a02c",fillOpacity:.95,opacity:.95,stroke:"#33a02c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"(S)-2-ethoxy-3-(4-(5-(4-(5-(methoxymethyl)isoxazol-3-yl)phenyl)-3-methylthiophen-2-yl)methoxyphenyl)propanoic acid"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Compound",data:{description:"An EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that interferes with the action of retinoid isomerohydrolase (EC 3.1.1.64).",id:"MESH:D012176",identity:"Compound::MESH:D012176",label:"Compound",name:"Retinoids",resource:"DrugBank"},degree:null,id:"Compound::MESH:D012176",label:"MESH:D012176",nlabel:"Compound",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"C"},keyshape:{fill:"#33a02c",fillOpacity:.95,opacity:.95,stroke:"#33a02c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"Retinoids"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Disease",data:{description:"Lack of blood supply to an area of the body, resulting in impairment of tissue oxygenation. [NCIT:C34738]",id:"MONDO:0005053",identity:"Disease::MONDO:0005053",label:"Disease",name:"ischemic disease",resource:"MONDO"},degree:null,id:"Disease::MONDO:0005053",label:"MONDO:0005053",nlabel:"Disease",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"D"},keyshape:{fill:"#fb9a99",fillOpacity:.95,opacity:.95,stroke:"#fb9a99"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"ischemic disease"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Disease",data:{description:"A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia. Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001) [NCIT:C3242]",id:"MONDO:0009693",identity:"Disease::MONDO:0009693",label:"Disease",name:"plasma cell myeloma",resource:"MONDO"},degree:null,id:"Disease::MONDO:0009693",label:"MONDO:0009693",nlabel:"Disease",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"D"},keyshape:{fill:"#fb9a99",fillOpacity:.95,opacity:.95,stroke:"#fb9a99"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"plasma cell myeloma"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Disease",data:{description:"A benign or malignant neoplasm involving the pancreas. [NCIT:C3305]",id:"MONDO:0021040",identity:"Disease::MONDO:0021040",label:"Disease",name:"pancreatic neoplasm",resource:"MONDO"},degree:null,id:"Disease::MONDO:0021040",label:"MONDO:0021040",nlabel:"Disease",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"D"},keyshape:{fill:"#fb9a99",fillOpacity:.95,opacity:.95,stroke:"#fb9a99"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"pancreatic neoplasm"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Gene",data:{description:"The protein encoded by this gene functions as a transcriptional coactivator for nuclear hormone receptors, including steroid, thyroid, retinoid, and vitamin D receptors. The encoded protein acts as an intermediary factor for the ligand-dependent activity of these nuclear receptors, which regulate their target genes upon binding of cognate response elements. This gene has been found to be involved in translocations that result in fusions with other genes in various cancers, including the lysine acetyltransferase 6A (KAT6A) gene in acute myeloid leukemia, the ETS variant 6 (ETV6) gene in acute lymphoblastic leukemia, and the hes related family bHLH transcription factor with YRPW motif 1 (HEY1) gene in mesenchymal chondrosarcoma. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016].",id:"ENTREZ:10499",identity:"Gene::ENTREZ:10499",label:"Gene",name:"NCOA2",resource:"ENTREZ"},degree:null,id:"Gene::ENTREZ:10499",label:"ENTREZ:10499",nlabel:"Gene",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"G"},keyshape:{fill:"#e31a1c",fillOpacity:.95,opacity:.95,stroke:"#e31a1c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"NCOA2"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Gene",data:{description:"This intronless gene encodes a transcription factor that contains a basic leucine zipper (bZIP) domain. The encoded protein functions as a homodimer but can also form heterodimers with CCAAT/enhancer-binding proteins alpha, delta, and gamma. Activity of this protein is important in the regulation of genes involved in immune and inflammatory responses, among other processes. The use of alternative in-frame AUG start codons results in multiple protein isoforms, each with distinct biological functions. [provided by RefSeq, Oct 2013].",id:"ENTREZ:1051",identity:"Gene::ENTREZ:1051",label:"Gene",name:"CEBPB",resource:"ENTREZ"},degree:null,id:"Gene::ENTREZ:1051",label:"ENTREZ:1051",nlabel:"Gene",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"G"},keyshape:{fill:"#e31a1c",fillOpacity:.95,opacity:.95,stroke:"#e31a1c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"CEBPB"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Gene",data:{description:"The protein encoded by this gene is a secreted chaperone that can under some stress conditions also be found in the cell cytosol. It has been suggested to be involved in several basic biological events such as cell death, tumor progression, and neurodegenerative disorders. Alternate splicing results in both coding and non-coding variants.[provided by RefSeq, May 2011].",id:"ENTREZ:1191",identity:"Gene::ENTREZ:1191",label:"Gene",name:"CLU",resource:"ENTREZ"},degree:null,id:"Gene::ENTREZ:1191",label:"ENTREZ:1191",nlabel:"Gene",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"G"},keyshape:{fill:"#e31a1c",fillOpacity:.95,opacity:.95,stroke:"#e31a1c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"CLU"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Gene",data:{description:"This gene encodes a member of the endothelin family of peptides. The encoded preproprotein undergoes proteolytic processing to generate a peptide before secretion by the vascular endothelial cells. The mature peptide has various biological activities such as vasoconstriction, cell proliferation, stimulation of hormone release and modulation of central nervous activity. Mice lacking the encoded protein exhibit neonatal lethality accompanied with numerous craniofacial and cardiovascular defects due to disruption in cranial and cardiac neural crest cell patterning during early embryogenesis. [provided by RefSeq, Feb 2016].",id:"ENTREZ:13614",identity:"Gene::ENTREZ:13614",label:"Gene",name:"Edn1",resource:"ENTREZ"},degree:null,id:"Gene::ENTREZ:13614",label:"ENTREZ:13614",nlabel:"Gene",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"G"},keyshape:{fill:"#e31a1c",fillOpacity:.95,opacity:.95,stroke:"#e31a1c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"Edn1"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Gene",data:{description:"This gene is ubiquitously expressed and is involved in the transcriptional coactivation of many different transcription factors. First isolated as a nuclear protein that binds to cAMP-response element binding protein (CREB), this gene is now known to play critical roles in embryonic development, growth control, and homeostasis by coupling chromatin remodeling to transcription factor recognition. The protein encoded by this gene has intrinsic histone acetyltransferase activity and also acts as a scaffold to stabilize additional protein interactions with the transcription complex. This protein acetylates both histone and non-histone proteins. This protein shares regions of very high sequence similarity with protein p300 in its bromodomain, cysteine-histidine-rich regions, and histone acetyltransferase domain. Mutations in this gene cause Rubinstein-Taybi syndrome (RTS). Chromosomal translocations involving this gene have been associated with acute myeloid leukemia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2009].",id:"ENTREZ:1387",identity:"Gene::ENTREZ:1387",label:"Gene",name:"CREBBP",resource:"ENTREZ"},degree:null,id:"Gene::ENTREZ:1387",label:"ENTREZ:1387",nlabel:"Gene",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"G"},keyshape:{fill:"#e31a1c",fillOpacity:.95,opacity:.95,stroke:"#e31a1c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"CREBBP"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Gene",data:{description:"The protein encoded by this gene is a member of the E2F family of transcription factors. The E2F family plays a crucial role in the control of cell cycle and action of tumor suppressor proteins and is also a target of the transforming proteins of small DNA tumor viruses. The E2F proteins contain several evolutionally conserved domains found in most members of the family. These domains include a DNA binding domain, a dimerization domain which determines interaction with the differentiation regulated transcription factor proteins (DP), a transactivation domain enriched in acidic amino acids, and a tumor suppressor protein association domain which is embedded within the transactivation domain.  This protein and another 2 members, E2F2 and E2F3, have an additional cyclin binding domain. This protein binds preferentially to retinoblastoma protein pRB in a cell-cycle dependent manner. It can mediate both cell proliferation and p53-dependent/independent apoptosis. [provided by RefSeq, Jul 2008].",id:"ENTREZ:1869",identity:"Gene::ENTREZ:1869",label:"Gene",name:"E2F1",resource:"ENTREZ"},degree:null,id:"Gene::ENTREZ:1869",label:"ENTREZ:1869",nlabel:"Gene",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"G"},keyshape:{fill:"#e31a1c",fillOpacity:.95,opacity:.95,stroke:"#e31a1c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"E2F1"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Gene",data:{description:"In Drosophila melanogaster, the 'Polycomb' group (PcG) of genes are part of a cellular memory system that is responsible for the stable inheritance of gene activity. PcG proteins form a large multimeric, chromatin-associated protein complex. The protein encoded by this gene has homology to the Drosophila PcG protein 'polyhomeotic' (Ph) and is known to heterodimerize with EDR1 and colocalize with BMI1 in interphase nuclei of human cells. The specific function in human cells has not yet been determined. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].",id:"ENTREZ:1912",identity:"Gene::ENTREZ:1912",label:"Gene",name:"PHC2",resource:"ENTREZ"},degree:null,id:"Gene::ENTREZ:1912",label:"ENTREZ:1912",nlabel:"Gene",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"G"},keyshape:{fill:"#e31a1c",fillOpacity:.95,opacity:.95,stroke:"#e31a1c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"PHC2"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Gene",data:{description:"This gene encodes an estrogen receptor and ligand-activated transcription factor. The canonical protein contains an N-terminal ligand-independent transactivation domain, a central DNA binding domain, a hinge domain, and a C-terminal ligand-dependent transactivation domain. The protein localizes to the nucleus where it may form either a homodimer or a heterodimer with estrogen receptor 2. The protein encoded by this gene regulates the transcription of many estrogen-inducible genes that play a role in growth, metabolism, sexual development, gestation, and other reproductive functions and is expressed in many non-reproductive tissues. The receptor encoded by this gene plays a key role in breast cancer, endometrial cancer, and osteoporosis. This gene is reported to have dozens of transcript variants due to the use of alternate promoters and alternative splicing, however, the full-length nature of many of these variants remain uncertain. [provided by RefSeq, Jul 2020].",id:"ENTREZ:2099",identity:"Gene::ENTREZ:2099",label:"Gene",name:"ESR1",resource:"ENTREZ"},degree:null,id:"Gene::ENTREZ:2099",label:"ENTREZ:2099",nlabel:"Gene",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"G"},keyshape:{fill:"#e31a1c",fillOpacity:.95,opacity:.95,stroke:"#e31a1c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"ESR1"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Gene",data:{description:"This gene encodes a member of the heat shock protein 90 family; these proteins are involved in signal transduction, protein folding and degradation and morphological evolution. This gene encodes the constitutive form of the cytosolic 90 kDa heat-shock protein and is thought to play a role in gastric apoptosis and inflammation. Alternative splicing results in multiple transcript variants. Pseudogenes have been identified on multiple chromosomes. [provided by RefSeq, Dec 2012].",id:"ENTREZ:3326",identity:"Gene::ENTREZ:3326",label:"Gene",name:"HSP90AB1",resource:"ENTREZ"},degree:null,id:"Gene::ENTREZ:3326",label:"ENTREZ:3326",nlabel:"Gene",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"G"},keyshape:{fill:"#e31a1c",fillOpacity:.95,opacity:.95,stroke:"#e31a1c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"HSP90AB1"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Gene",data:{description:"This gene encodes a protein that is secreted by white adipocytes into the circulation and plays a major role in the regulation of energy homeostasis. Circulating leptin binds to the leptin receptor in the brain, which activates downstream signaling pathways that inhibit feeding and promote energy expenditure. This protein also has several endocrine functions, and is involved in the regulation of immune and inflammatory responses, hematopoiesis, angiogenesis, reproduction, bone formation and wound healing. Mutations in this gene and its regulatory regions cause severe obesity and morbid obesity with hypogonadism in human patients. A mutation in this gene has also been linked to type 2 diabetes mellitus development. [provided by RefSeq, Aug 2017].",id:"ENTREZ:3952",identity:"Gene::ENTREZ:3952",label:"Gene",name:"LEP",resource:"ENTREZ"},degree:null,id:"Gene::ENTREZ:3952",label:"ENTREZ:3952",nlabel:"Gene",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"G"},keyshape:{fill:"#e31a1c",fillOpacity:.95,opacity:.95,stroke:"#e31a1c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"LEP"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Gene",data:{description:"The protein encoded by this gene has a long and a short form, generated by use of alternative translational start codons. The long form is expressed in steroidogenic tissues such as testis, where it converts cholesteryl esters to free cholesterol for steroid hormone production. The short form is expressed in adipose tissue, among others, where it hydrolyzes stored triglycerides to free fatty acids. [provided by RefSeq, Jul 2008].",id:"ENTREZ:3991",identity:"Gene::ENTREZ:3991",label:"Gene",name:"LIPE",resource:"ENTREZ"},degree:null,id:"Gene::ENTREZ:3991",label:"ENTREZ:3991",nlabel:"Gene",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"G"},keyshape:{fill:"#e31a1c",fillOpacity:.95,opacity:.95,stroke:"#e31a1c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"LIPE"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Gene",data:{description:"This gene encodes a bifunctional protein that catalyzes the last two steps of the de novo purine biosynthetic pathway. The N-terminal domain has phosphoribosylaminoimidazolecarboxamide formyltransferase activity, and the C-terminal domain has IMP cyclohydrolase activity. A mutation in this gene results in AICA-ribosiduria. [provided by RefSeq, Sep 2009].",id:"ENTREZ:471",identity:"Gene::ENTREZ:471",label:"Gene",name:"ATIC",resource:"ENTREZ"},degree:null,id:"Gene::ENTREZ:471",label:"ENTREZ:471",nlabel:"Gene",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"G"},keyshape:{fill:"#e31a1c",fillOpacity:.95,opacity:.95,stroke:"#e31a1c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"ATIC"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Gene",data:{description:"This gene encodes a member of the peroxisome proliferator-activated receptor (PPAR) subfamily of nuclear receptors. PPARs form heterodimers with retinoid X receptors (RXRs) and these heterodimers regulate transcription of various genes. Three subtypes of PPARs are known: PPAR-alpha, PPAR-delta, and PPAR-gamma. The protein encoded by this gene is PPAR-gamma and is a regulator of adipocyte differentiation. Additionally, PPAR-gamma has been implicated in the pathology of numerous diseases including obesity, diabetes, atherosclerosis and cancer. Alternatively spliced transcript variants that encode different isoforms have been described. [provided by RefSeq, Jul 2008].",id:"ENTREZ:5468",identity:"Gene::ENTREZ:5468",label:"Gene",name:"PPARG",resource:"ENTREZ"},degree:null,id:"Gene::ENTREZ:5468",label:"ENTREZ:5468",nlabel:"Gene",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"G"},keyshape:{fill:"#e31a1c",fillOpacity:.95,opacity:.95,stroke:"#e31a1c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"PPARG"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Gene",data:{description:"MED18 is a component of the Mediator complex, which is a coactivator for DNA-binding factors that activate transcription via RNA polymerase II (Sato et al., 2003 [PubMed 12584197]).[supplied by OMIM, Oct 2008].",id:"ENTREZ:54797",identity:"Gene::ENTREZ:54797",label:"Gene",name:"MED18",resource:"ENTREZ"},degree:null,id:"Gene::ENTREZ:54797",label:"ENTREZ:54797",nlabel:"Gene",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"G"},keyshape:{fill:"#e31a1c",fillOpacity:.95,opacity:.95,stroke:"#e31a1c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"MED18"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Gene",data:{description:"The protein encoded by this gene belongs to the ser/thr protein kinase family. It is the catalytic subunit of the 5'-prime-AMP-activated protein kinase (AMPK). AMPK is a cellular energy sensor conserved in all eukaryotic cells. The kinase activity of AMPK is activated by the stimuli that increase the cellular AMP/ATP ratio. AMPK regulates the activities of a number of key metabolic enzymes through phosphorylation. It protects cells from stresses that cause ATP depletion by switching off ATP-consuming biosynthetic pathways. Alternatively spliced transcript variants encoding distinct isoforms have been observed. [provided by RefSeq, Jul 2008].",id:"ENTREZ:5562",identity:"Gene::ENTREZ:5562",label:"Gene",name:"PRKAA1",resource:"ENTREZ"},degree:null,id:"Gene::ENTREZ:5562",label:"ENTREZ:5562",nlabel:"Gene",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"G"},keyshape:{fill:"#e31a1c",fillOpacity:.95,opacity:.95,stroke:"#e31a1c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"PRKAA1"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Gene",data:{description:"This gene encodes a zinc finger transcription factor thought to play a role in the development of abducens motor neurons. Defects in this gene are a cause of Duane-radial ray syndrome (DRRS). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2015].",id:"ENTREZ:57167",identity:"Gene::ENTREZ:57167",label:"Gene",name:"SALL4",resource:"ENTREZ"},degree:null,id:"Gene::ENTREZ:57167",label:"ENTREZ:57167",nlabel:"Gene",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"G"},keyshape:{fill:"#e31a1c",fillOpacity:.95,opacity:.95,stroke:"#e31a1c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"SALL4"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Gene",data:{description:"This locus encodes an AT-rich DNA interacting domain-containing protein. The encoded protein is a component of the SWI/SNF chromatin remodeling complex and may play a role in cell-cycle activation. The protein encoded by this locus is similar to AT-rich interactive domain-containing protein 1A. These two proteins function as alternative, mutually exclusive ARID-subunits of the SWI/SNF complex. The associated complexes play opposing roles. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2016].",id:"ENTREZ:57492",identity:"Gene::ENTREZ:57492",label:"Gene",name:"ARID1B",resource:"ENTREZ"},degree:null,id:"Gene::ENTREZ:57492",label:"ENTREZ:57492",nlabel:"Gene",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"G"},keyshape:{fill:"#e31a1c",fillOpacity:.95,opacity:.95,stroke:"#e31a1c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"ARID1B"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Gene",data:{description:"This gene encodes a member of the Jumonji, AT-rich interactive domain 1 (JARID1) histone demethylase protein family. The encoded protein plays a role in gene regulation through the histone code by specifically demethylating lysine 4 of histone H3. The encoded protein interacts with many other proteins, including retinoblastoma protein, and is implicated in the transcriptional regulation of Hox genes and cytokines. This gene may play a role in tumor progression. [provided by RefSeq, Aug 2013].",id:"ENTREZ:5927",identity:"Gene::ENTREZ:5927",label:"Gene",name:"KDM5A",resource:"ENTREZ"},degree:null,id:"Gene::ENTREZ:5927",label:"ENTREZ:5927",nlabel:"Gene",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"G"},keyshape:{fill:"#e31a1c",fillOpacity:.95,opacity:.95,stroke:"#e31a1c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"KDM5A"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Gene",data:{description:"NF-kappa-B is a ubiquitous transcription factor involved in several biological processes. It is held in the cytoplasm in an inactive state by specific inhibitors. Upon degradation of the inhibitor, NF-kappa-B moves to the nucleus and activates transcription of specific genes. NF-kappa-B is composed of NFKB1 or NFKB2 bound to either REL, RELA, or RELB. The most abundant form of NF-kappa-B is NFKB1 complexed with the product of this gene, RELA. Four transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011].",id:"ENTREZ:5970",identity:"Gene::ENTREZ:5970",label:"Gene",name:"RELA",resource:"ENTREZ"},degree:null,id:"Gene::ENTREZ:5970",label:"ENTREZ:5970",nlabel:"Gene",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"G"},keyshape:{fill:"#e31a1c",fillOpacity:.95,opacity:.95,stroke:"#e31a1c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"RELA"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Gene",data:{description:"This gene belongs to the RING finger family, members of which encode proteins characterized by a RING domain, a zinc-binding motif related to the zinc finger domain. The gene product can bind DNA and can act as a transcriptional repressor. It is associated with the multimeric polycomb group protein complex. The gene product interacts with the polycomb group proteins BMI1, EDR1, and CBX4, and colocalizes with these proteins in large nuclear domains. It interacts with the CBX4 protein via its glycine-rich C-terminal domain. The gene maps to the HLA class II region, where it is contiguous with the RING finger genes FABGL and HKE4. [provided by RefSeq, Jul 2008].",id:"ENTREZ:6015",identity:"Gene::ENTREZ:6015",label:"Gene",name:"RING1",resource:"ENTREZ"},degree:null,id:"Gene::ENTREZ:6015",label:"ENTREZ:6015",nlabel:"Gene",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"G"},keyshape:{fill:"#e31a1c",fillOpacity:.95,opacity:.95,stroke:"#e31a1c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"RING1"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Gene",data:{description:"Focal adhesions are actin-rich structures that enable cells to adhere to the extracellular matrix and at which protein complexes involved in signal transduction assemble. Zyxin is a zinc-binding phosphoprotein that concentrates at focal adhesions and along the actin cytoskeleton. Zyxin has an N-terminal proline-rich domain and three LIM domains in its C-terminal half. The proline-rich domain may interact with SH3 domains of proteins involved in signal transduction pathways while the LIM domains are likely involved in protein-protein binding. Zyxin may function as a messenger in the signal transduction pathway that mediates adhesion-stimulated changes in gene expression and may modulate the cytoskeletal organization of actin bundles. Alternative splicing results in multiple transcript variants that encode the same isoform. [provided by RefSeq, Jul 2008].",id:"ENTREZ:7791",identity:"Gene::ENTREZ:7791",label:"Gene",name:"ZYX",resource:"ENTREZ"},degree:null,id:"Gene::ENTREZ:7791",label:"ENTREZ:7791",nlabel:"Gene",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"G"},keyshape:{fill:"#e31a1c",fillOpacity:.95,opacity:.95,stroke:"#e31a1c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"ZYX"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Gene",data:{description:"The protein encoded by this gene is a nuclear transcriptional co-activator for peroxisome proliferator activated receptor alpha. The encoded protein contains a zinc finger and is a helicase that appears to be part of the peroxisome proliferator activated receptor alpha interacting complex. This gene is a member of the DNA2/NAM7 helicase gene family. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].",id:"ENTREZ:85441",identity:"Gene::ENTREZ:85441",label:"Gene",name:"HELZ2",resource:"ENTREZ"},degree:null,id:"Gene::ENTREZ:85441",label:"ENTREZ:85441",nlabel:"Gene",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"G"},keyshape:{fill:"#e31a1c",fillOpacity:.95,opacity:.95,stroke:"#e31a1c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"HELZ2"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Gene",data:{description:"The protein encoded by this gene belongs to the CDK subfamily of the Ser/Thr protein kinase family. The CDK subfamily members are highly similar to the gene products of S. cerevisiae cdc28, and S. pombe cdc2, and are known to be essential for cell cycle progression. This kinase has been shown to play a role in cellular proliferation and its function is limited to cell cycle G2-M phase. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2009].",id:"ENTREZ:8558",identity:"Gene::ENTREZ:8558",label:"Gene",name:"CDK10",resource:"ENTREZ"},degree:null,id:"Gene::ENTREZ:8558",label:"ENTREZ:8558",nlabel:"Gene",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"G"},keyshape:{fill:"#e31a1c",fillOpacity:.95,opacity:.95,stroke:"#e31a1c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"CDK10"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Gene",data:{description:"The protein encoded by this gene acts as a transcriptional coactivator for steroid and nuclear hormone receptors. It is a member of the p160/steroid receptor coactivator (SRC) family and like other family members has histone acetyltransferase activity and contains a nuclear localization signal, as well as bHLH and PAS domains. The product of this gene binds nuclear receptors directly and stimulates the transcriptional activities in a hormone-dependent fashion. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008].",id:"ENTREZ:8648",identity:"Gene::ENTREZ:8648",label:"Gene",name:"NCOA1",resource:"ENTREZ"},degree:null,id:"Gene::ENTREZ:8648",label:"ENTREZ:8648",nlabel:"Gene",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"G"},keyshape:{fill:"#e31a1c",fillOpacity:.95,opacity:.95,stroke:"#e31a1c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"NCOA1"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Gene",data:{description:"The protein encoded by this gene is a regulator of apoptosis and is structurally similar to caspase-8. However, the encoded protein lacks caspase activity and appears to be itself cleaved into two peptides by caspase-8. Several transcript variants encoding different isoforms have been found for this gene, and partial evidence for several more variants exists. [provided by RefSeq, Feb 2011].",id:"ENTREZ:8837",identity:"Gene::ENTREZ:8837",label:"Gene",name:"CFLAR",resource:"ENTREZ"},degree:null,id:"Gene::ENTREZ:8837",label:"ENTREZ:8837",nlabel:"Gene",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"G"},keyshape:{fill:"#e31a1c",fillOpacity:.95,opacity:.95,stroke:"#e31a1c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"CFLAR"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Gene",data:{description:"Histones play a critical role in transcriptional regulation, cell cycle progression, and developmental events. Histone acetylation/deacetylation alters chromosome structure and affects transcription factor access to DNA. The protein encoded by this gene belongs to the histone deacetylase/acuc/apha family. It has histone deacetylase activity and represses transcription when tethered to a promoter. It may participate in the regulation of transcription through its binding with the zinc-finger transcription factor YY1. This protein can also down-regulate p53 function and thus modulate cell growth and apoptosis. This gene is regarded as a potential tumor suppressor gene. [provided by RefSeq, Jul 2008].",id:"ENTREZ:8841",identity:"Gene::ENTREZ:8841",label:"Gene",name:"HDAC3",resource:"ENTREZ"},degree:null,id:"Gene::ENTREZ:8841",label:"ENTREZ:8841",nlabel:"Gene",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"G"},keyshape:{fill:"#e31a1c",fillOpacity:.95,opacity:.95,stroke:"#e31a1c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"HDAC3"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Gene",data:{description:"The activation of gene transcription is a multistep process that is triggered by factors that recognize transcriptional enhancer sites in DNA. These factors work with co-activators to direct transcriptional initiation by the RNA polymerase II apparatus. The protein encoded by this gene is a subunit of the CRSP (cofactor required for SP1 activation) complex, which, along with TFIID, is required for efficient activation by SP1. This protein is also a component of other multisubunit complexes e.g. thyroid hormone receptor-(TR-) associated proteins which interact with TR and facilitate TR function on DNA templates in conjunction with initiation factors and cofactors. [provided by RefSeq, Jul 2008].",id:"ENTREZ:9440",identity:"Gene::ENTREZ:9440",label:"Gene",name:"MED17",resource:"ENTREZ"},degree:null,id:"Gene::ENTREZ:9440",label:"ENTREZ:9440",nlabel:"Gene",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"G"},keyshape:{fill:"#e31a1c",fillOpacity:.95,opacity:.95,stroke:"#e31a1c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"MED17"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Gene",data:{description:"This gene encodes a protein that mediates ligand-independent transcription repression of thyroid-hormone and retinoic-acid receptors by promoting chromatin condensation and preventing access of the transcription machinery. It is part of a complex which also includes histone deacetylases and transcriptional regulators similar to the yeast protein Sin3p. This gene is located between the Charcot-Marie-Tooth and Smith-Magenis syndrome critical regions on chromosome 17. Alternate splicing results in multiple transcript variants. Pseudogenes of this gene are found on chromosomes 17 and 20.[provided by RefSeq, Jun 2010].",id:"ENTREZ:9611",identity:"Gene::ENTREZ:9611",label:"Gene",name:"NCOR1",resource:"ENTREZ"},degree:null,id:"Gene::ENTREZ:9611",label:"ENTREZ:9611",nlabel:"Gene",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"G"},keyshape:{fill:"#e31a1c",fillOpacity:.95,opacity:.95,stroke:"#e31a1c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"NCOR1"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"Gene",data:{description:"This gene encodes a nuclear receptor co-repressor that mediates transcriptional silencing of certain target genes. The encoded protein is a member of a family of thyroid hormone- and retinoic acid receptor-associated co-repressors. This protein acts as part of a multisubunit complex which includes histone deacetylases to modify chromatin structure that prevents basal transcriptional activity of target genes. Aberrant expression of this gene is associated with certain cancers. Alternate splicing results in multiple transcript variants encoding different isoforms.[provided by RefSeq, Apr 2011].",id:"ENTREZ:9612",identity:"Gene::ENTREZ:9612",label:"Gene",name:"NCOR2",resource:"ENTREZ"},degree:null,id:"Gene::ENTREZ:9612",label:"ENTREZ:9612",nlabel:"Gene",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"G"},keyshape:{fill:"#e31a1c",fillOpacity:.95,opacity:.95,stroke:"#e31a1c"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"NCOR2"}},type:"graphin-circle",x:null,y:null},{category:"node",cluster:"MolecularFunction",data:{description:"Combining with an icosanoid to initiate a change in cell activity.",id:"GO:0004953",identity:"MolecularFunction::GO:0004953",label:"MolecularFunction",name:"icosanoid receptor activity",resource:"GO"},degree:null,id:"MolecularFunction::GO:0004953",label:"GO:0004953",nlabel:"MolecularFunction",style:{icon:{color:"#000",fill:"#000",size:15,type:"text",value:"M"},keyshape:{fill:"#b2df8a",fillOpacity:.95,opacity:.95,stroke:"#b2df8a"},label:{fill:"#000",fontSize:12,offset:0,position:"bottom",value:"icosanoid receptor activity"}},type:"graphin-circle",x:null,y:null}]}}]);
